The exceptional conducting nature of graphene makes it a viable candidate for enhancing the effectiveness of photocatalytic and biomedical nanomaterials. Herein, the immobilization of monodispersed silicon dioxide (SiO2) nanoparticles on multiple graphene layers is demonstrated for intercalation of graphene nanoplatelets. Interestingly, the addition of graphene nanoplatelets with SiO2 nanoparticles enhances the photocatalytic efficiency from 46% to 99%. For biomedical applications, it is found that 75% of Gram positive and 50% of Gram negative bacteria have been killed; hence, bacterial proliferation is significantly restricted. Further, the cytotoxicity study reveals that the synthesised nanocomposites are non-toxic for both normal (human corneal epithelial cells) and cancerous (MCF-7, HEp-2) cell lines which signify their potential as carriers for drug delivery. The prepared nanocomposites with a controlled amount of carbon in the form of graphene can be employed for photocatalysis based waste water remediation, biomedicine, and nanodrug delivery.
No takes yet. Share an insight, caveat, or question.
A 2017 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: